Package Leaflet: Information for the User
Olazax 5 mg tablets EFG
Olazax 7.5 mg tablets EFG
Olazax 10 mg tablets EFG
Olazax 15 mg tablets EFG
Olazax 20 mg tablets EFG
Olanzapine
Read the entire package leaflet carefully before you start taking this medicine, because it contains important information for you.
Olazax contains the active substance olanzapine. Olazax belongs to a group of medicines called antipsychotics and is indicated for the treatment of the following diseases:
OLAZAX has been shown to prevent the recurrence of these symptoms in patients with bipolar disorder whose manic episodes have responded to treatment with olanzapine.
Warnings and precautions
If you suffer from any of the following diseases, tell your doctor as soon as possible:
If you have dementia, you or your caregiver or family member should inform your doctor if you have ever had a stroke or a lack of blood flow to the brain.
As a routine precaution, if you are over 65 years old, it would be advisable for your doctor to check your blood pressure.
Children and adolescents
Patients under 18 years of age should not take Olazax.
Only use other medicines at the same time as Olazax if your doctor authorizes it. You may feel drowsy if you combine Olazax with antidepressants or medicines for anxiety or sleep aids (tranquilizers).
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
In particular, tell your doctor if you are taking:
You should not drink alcohol if you have been given Olazax, as it may cause drowsiness.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. You should not take this medicine when you are breastfeeding, as small amounts of Olazax may pass into breast milk.
The following symptoms may occur in newborn babies of mothers who have been treated with Olazax in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
There is a risk of drowsiness when taking Olazax. If this happens to you, do not drive or use machinery. Consult your doctor.
The Olazax tablets contain aspartame, which is a source of phenylalanine.The Olanzapine Glenmark tablets contain aspartame, which is a source of phenylalanine. Therefore, this medicine may be harmful to people with phenylketonuria.
Follow the instructions for administration of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Consult your doctor or pharmacist if you have any doubts.
Your doctor will tell you how many Olazax tablets you should take and for how long. The daily dose of Olazax ranges from 5 mg to 20 mg. Consult your doctor if you experience symptoms again, but do not stop taking Olazax unless your doctor tells you to.
You should take your Olazax tablets once a day, following your doctor's instructions. Try to take the tablets at the same time every day. You can take them with or without food. The Olazax film-coated tablets are for oral administration. You should swallow the Olazax tablets whole with water.
Patient who have taken more Olazax than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and a reduced level of consciousness. Other symptoms may include: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, drowsiness or lethargy, slowing of respiratory rate, aspiration, increased or decreased blood pressure, and abnormal heart rhythms. Contact your doctor or go to the hospital immediately if you notice any of the above symptoms. Show the doctor the package with the tablets.
Take your tablets as soon as you remember. Do not take a double dose to make up for forgotten doses.
Do not stop treatment just because you feel better. It is very important that you continue taking Olazax while your doctor tells you to.
If you stop taking Olazax suddenly, you may experience symptoms such as sweating, insomnia, tremors, anxiety, or nausea and vomiting. Your doctor may suggest that you gradually reduce the dose before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you have:
Very common side effects (may affect more than 1 in 10 people) include:
Common side effects (may affect up to 1 in 10 people) include:
Uncommon side effects (may affect up to 1 in 100 people) include:
Rare side effects (may affect up to 1 in 1,000 people) include:
Very rare side effects (may affect up to 1 in 10,000 people) include:
During treatment with olanzapine, elderly patients with dementia may experience stroke, pneumonia, urinary incontinence, falls, excessive fatigue, visual hallucinations, elevated body temperature, redness of the skin, and walking problems. Some deaths have been reported in this particular group of patients.
Olazax may worsen symptoms in patients with Parkinson's disease.
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this package leaflet. You can also report side effects directly through the national reporting system included in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging and blister. The expiry date refers to the last day of the month indicated.
Store below 30 °C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Olazax 5 mg:
round, flat, beveled-edge tablets, yellow in color with a "B" engraved on one face.
Olazax 7.5 mg:
round, flat, beveled-edge tablets, yellow in color with a "C" engraved on one face.
Olazax 10 mg:
round, flat, beveled-edge tablets, yellow in color with "OL" engraved on one face and a "D" engraved on the other face.
Olazax 15 mg:
round, flat, beveled-edge tablets, yellow in color with "OL" engraved on one face and an "E" engraved on the other face.
Olazax 20 mg:
round, flat, beveled-edge tablets, yellow in color with "OL" engraved on one face and an "F" engraved on the other face.
Olazax, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg is presented in aluminum blister packs of 28 & 56 tablets
Not all pack sizes may be marketed.
Marketing authorization holder
Glenmark Pharmaceuticals s.r.o. Hvezdova 1716/2b, 140 78 Praha 4, Czech Republic
Manufacturer Glenmark Pharmaceuticals s.r.o. Hvezdova 1716/2b, 140 78 Praha 4, Czech Republic
Detailed information on this medicine is available on the European Medicines Agency (EMA) website http://www.emea.europa.eu